Skip to main content
NCBI home page
Molecules logoLink to Molecules
. 2023 May 25;28(11):4339. doi: 10.3390/molecules28114339

Formal [3 + 2] Cycloaddition of α-Imino Esters with Azo Compounds: Facile Construction of Pentasubstituted 1,2,4-Triazoline Skeletons

Yasushi Yoshida 1,*, Hidetoshi Ida 1, Takashi Mino 1, Masami Sakamoto 1
Editors: Alexander F Khlebnikov1, Nikolai V Rostovskii1
PMCID: PMC10254835  PMID: 37298816

Abstract

1,2,4-Triazole and 1,2,4-triazoline are important components of bioactive molecules and catalysts employed in organic synthesis. Therefore, the efficient synthesis of these components has received significant research attention. However, studies on their structural diversity remain lacking. Previously, we developed chiral phase-transfer-catalyzed asymmetric reactions of α-imino carbonyl compounds with α,β-unsaturated carbonyl compounds and haloalkanes. In this study, we demonstrate the formal [3 + 2] cycloaddition reaction of α-imino esters with azo compounds under Brønsted base catalysis, resulting in the corresponding 1,2,4-triazolines in high yields. The results revealed that a wide range of substrates and reactants can be applied, irrespective of their steric and electronic characteristics. The present reaction made the general preparation of 3-aryl pentasubstituted 1,2,4-triazolines possible for the first time. Furthermore, a mechanistic study suggested that the reaction proceeds without isomerization into the aldimine form.

Keywords: cycloaddition; α-imino ester; azo compound; 1,2,4-triazoline; 1,2,4-triazole

1. Introduction

1,2,4-Triazoles are fundamental core components in biologically active molecules, such as fluconazole and voriconazole (Figure 1) [1,2,3,4]. They are also employed in chiral ligands as well as metal and organocatalysts, such as chiral biscarbene ligands [5], 1,2,4-triazole anion catalysts [6], and Rovis catalysts [7]. Efficient methods for preparing 1,2,4-triazoles have been extensively investigated, and they are mainly synthesized via the Cu-catalyzed oxidative reaction of 2-aminopyridines with nitriles [8], C–H amidation/cyclization of azomethine imines [9], intramolecular oxidative N–N bond formation [10], electrochemical oxidation [11], and other methods [12,13,14,15,16,17].

1,2,4-Triazoline is also an important motif owing to its wide utility as a biologically active compound, including as an antitumor-active molecule [18]. Furthermore, it is a useful precursor for synthesizing 1,2,4-triazole [19]. Therefore, efficient synthesis methods for 1,2,4-triazolines have been investigated [19,20,21,22,23,24,25,26]. In 2017, Li, Tang, and co-workers reported the visible-light-induced cyclization of azirines with azodicarboxylate, which formed the corresponding 1,2,4-triazolines in high yields [26]. Although synthetic methods for 1,2,4-triazolines have been developed, candidates with pentasubstituted structures have rarely been synthesized under metal-free conditions. In 2010, Tepe and co-workers prepared the 3-alkyl pentasubstituted 1,2,4-triazolines by the conjugate addition of oxazolones with azodicarboxylate, resulting in corresponding products in 50–100% yield (Figure 1a) [19]. Although an efficient synthesis method for the exclusive preparation of 3-alkyl pentasubstituted 1,2,4-triazolines has been developed, their 3-aryl-substituted compounds are rarely synthesized. In 1992, Ibata and co-workers reported the abnormal Diels–Alder reaction of oxazoles with a diethyl azodicarboxylate, which formed pentasubstituted 1,2,4-triazolines in 25–92% yield with a longer reaction time of more than 23.5 h (Figure 1b) [20]. Therefore, the development of a general and facile method for the metal-free preparation of 3-aryl pentasubstituted 1,2,4-triazolines is highly desirable.

α-Imino esters are useful molecular scaffolds owing to their widespread application as electrophiles [27,28,29,30,31,32,33,34,35]. Previously, α-imino esters have been utilized as substrates for umpolung reactions with several nucleophiles [36,37,38,39,40]. We also developed an asymmetric umpolung reaction of α-imino esters with α,β-unsaturated carbonyl compounds and haloalkanes, which provided chiral amine derivatives in high yields (Figure 1c) [41,42,43,44,45]. In this work, a formal [3 + 2] cycloaddition reaction of α-imino esters with azodicarboxylates was developed, which formed useful 3-aryl and 3-alkyl pentasubstituted 1,2,4-triazolines in high yields without the addition of an external oxidant (Figure 1d). The present reaction made the metal-free general preparation of 3-aryl pentasubstituted 1,2,4-triazolines under the mild condition possible for the first time.

Figure 1.

Figure 1

Open in a new tab

Useful molecules bearing 1,2,4-triazole and 1,2,4-triazoline skeleton and synthesis of 1,2,4-triazolines in (a) Tepe’s study [19], (b) Ibata’s study [20], (c) our previous study [36,37,38,39,40], and (d) present work.

2. Results and Discussion

2.1. Reaction Condition Optimization

The reaction conditions for the synthesis of 1,2,4-triazoline 3aa were optimized using α-imino ester 1a and diisopropyl azodicarboxylate (DIAD, 2a) as the substrate and reactant, respectively (Table 1). Solvent screening was conducted using 1.0 equivalent of 1a and 2.0 equivalent of 2a in the presence of 50 mol% 1,8-diazabicyclo [5.4.0]undec-7-ene (DBU) as a base at −40 °C for 18 h. The reaction in nonpolar solvents, such as toluene, provided 3aa in only a 9% yield, and the use of ethereal solvents and methanol resulted in poor yields (entries 1–5). Finally, the reaction in dichloromethane afforded 3aa in a 43% yield. Next, the amount of DBU was screened, and the use of 100 and 150 mol% DBU did not increase the yield of 3aa (entries 6 and 7). Subsequently, the effect of the reaction temperature was examined at −20 °C, 0 °C, and room temperature, and the reaction at 0 °C produced 3aa in the highest yield of 61% (entries 8–10). The reaction was completed after 1 h (entries 11 and 12). The reaction workup procedure was changed from short column on silica gel to extraction with dichloromethane, which increased the yield of 3aa to 88%, and 3aa was isolated in a 72% yield (entry 13). Finally, triethylamine was employed as an inexpensive organic base; however, 3aa was obtained in a low yield (entry 14).

Table 1.

Reaction condition optimization.

graphic file with name molecules-28-04339-i001.jpg
Entry Solvent X Temp. (°C) Time (h) Yield (%) b
1 toluene 50 −40 18 9
2 Et2O 50 −40 18 4
3 CH2Cl2 50 −40 18 43
4 tetrahydrofuran 50 −40 18 28
5 MeOH 50 −40 18 0
6 CH2Cl2 100 −40 18 43
7 CH2Cl2 150 −40 18 42
8 CH2Cl2 50 −20 18 53
9 CH2Cl2 50 0 18 61
10 CH2Cl2 50 r.t 18 51
11 CH2Cl2 50 0 1 64
12 CH2Cl2 50 0 53 64
13 c CH2Cl2 50 0 1 88 (72 d)
14 c,e CH2Cl2 50 0 1 10
Open in a new tab

a 0.05 mmol scale reaction. b All yields were obtained via 1H-NMR analysis using 1,3,5-trimethoxybenzene as an internal standard. c Workup method was changed from short column to extraction. d Isolated yield. e Triethylamine was employed instead of DBU as a base.

2.2. Substrate Scope

We then investigated the scope of the ester moiety in the substrate using DIAD as the reactant (Scheme 1). When the bulky tert-butyl ester was employed, the product 3aa was isolated in a 72% yield, whereas the use of less bulky isopropyl and methyl esters resulted in 44% and 22% yields, respectively.

Scheme 1.

Scheme 1

Open in a new tab

Scope of the ester moiety of 1.

Furthermore, the scope of the azo compounds was investigated using 1a as a substrate under the optimal conditions (Scheme 2). The use of DIAD formed 3aa in a 72% yield, and the utilization of diethyl azodicarboxylate (DEAD, 2b) or di-tert-butyl azodicarboxylate (2c) resulted in corresponding products 3ab and 3ac in 53% or 78% yields, respectively. These observations indicated that increasing the bulkiness of both the substrate and reactant increases the yield of the product. The employment of azobenzene (2d) did not provide any cyclized product 3ad.

Scheme 2.

Scheme 2

Open in a new tab

Scope of azo compounds.

Subsequently, the substrate scope of the R1 group was determined. The substrate scope using the inexpensive 2a and 2c as the reactants is presented in Scheme 3. In the case of 2a as a reactant, R1 groups with electron-donating substituents, such as p-tolyl and p-anisyl groups, were examined, and the products 3fa and 3ga were isolated in 61% and 65% yields, respectively. Substrates with m- and o-tolyl groups were well tolerated, and 3ea and 3da were obtained in 53% and 60% yields, respectively. Furthermore, the electron-withdrawing substituents 1h, 1i, and 1j were used in the 1,2,4-triazoline synthesis, and the products were obtained in 43%, 50%, and 42% yields, respectively. The present reaction was successfully applied to several substituted substrates, and the products were obtained in moderate yields. Further substrate scope studies were conducted using the bulky azo compound 2c as the reactant. First, the same substrates used for evaluating the substrate scope using DIAD (2a) were employed. The products 3dc–3jc were obtained in 65–87% yields, which were higher than those obtained using DIAD as the reactant. Moreover, 2-naphthyl-substituted 1k and tert-butyl-substituted 1l were applied to the present reaction, which formed 3kc and 3lc in 76% and 29% yields, respectively. These results show that the present reaction is applicable to both aryl- and alkyl-substituted substrates.

Scheme 3.

Scheme 3

Open in a new tab

Substrate scope using 2a and 2c as reactants.

Next, we examined the necessity for a 4-nitrobenzyl moiety on the substrate (Scheme 4). 4-Trifluoromethylbenzyl-substituted 1m and benzyl-substituted 1n were prepared and applied to the present reaction, which did not afford any 1,2,4-triazoline products. Only the substrate and its hydrolysis product were obtained together with the complex mixture, thereby indicating the importance of the 4-nitro group on the benzyl moiety in the production of 1,2,4-triazolines.

Scheme 4.

Scheme 4

Open in a new tab

Scope of the aromatic substituent on the imine moiety.

2.3. Asymmetric Synthesis

The asymmetric synthesis of 1,2,4-triazolines was attempted to demonstrate the utility of this reaction (Scheme 5). Here, 1a was reacted with 2c in the presence of 2.0 mol% of chiral phase-transfer catalyst 4 and 150 mol% of potassium hydroxide in dichloromethane at 0 °C, which provided 1,4-addition product 5ac in a 57% yield together with a small amount of the desired 3ac. Notably, 5ac was converted into 1,2,4-triazole 3ac using a 1.0 equivalent of 2c and 50 mol% of DBU in dichloromethane in a 47% yield. The enantiopurity of the synthesized 3ac was evaluated via high-performance liquid chromatography using a chiral stationary phase column, and it was found to be a racemate.

Scheme 5.

Scheme 5

Open in a new tab

Attempt at the asymmetric synthesis of 3ac.

2.4. Reaction Mechanistic Study

Finally, to clarify the reaction pathway, α-imino ester 1a was isomerized into aldimine 1a′ because the α-imino ester isomerizes into aldimine under basic conditions [46]. Here, 1a′ was employed as the substrate under the same conditions as that of the asymmetric synthesis of 3ac, which directly provided 1,2,4-triazoline 3ac in a 65% yield and a shorter reaction time; however, 5ac was not produced (Scheme 6). These results indicate that the reaction mechanisms for each substrate were different.

Scheme 6.

Scheme 6

Open in a new tab

Reaction from aldimine 1a′.

Based on the above results, we propose a plausible reaction mechanism (Figure 2). First, the benzylic proton of substrate 1a is deprotonated by potassium hydroxide and its counteranion is changed to the chiral ammonium salt to form a 2-aza allyl anion intermediate, which attacks the azo compounds in a 1,4-addition reaction to yield ketimine 5ac-ionic. Finally, the cyclization of the hydrazine moiety with the imine moiety occurs, forming 1,2,4-triazolidine 6ac-ionic, followed by the oxidation of the amine part by the additional azo compound to afford 3ac [47]. In contrast, 1a′ reacts with potassium hydroxide to form an enolate intermediate, which is different from the reaction starting from 1a. The as-formed intermediate then reacts with azo compound 2c to form aldimine 5ac′-ionic, which undergoes cyclization to form 1,2,4-triazolidine 6ac. The reaction rate difference between 1a and 1a′ can be explained by these plausible reaction mechanisms. In this reaction, 1a did not isomerize into 1a′ under the reaction conditions, and the aldimine intermediate 5ac′-ionic could be cyclized more rapidly than the ketimine intermediate 5ac-ionic owing to its low steric hindrance around the electrophilic site. Therefore, the overall rate for the formation of 3ac increased, and no intermediate 5ac′-ionic was observed, even after stirring for 18 h.

Figure 2.

Figure 2

Open in a new tab

Plausible reaction mechanism.

3. Materials and Methods

1H- and 13C-NMR spectra were recorded with Bruker (Billerica, MA, USA) AVANCE III-400M (1H-NMR 400 MHz, 13C-NMR 100 MHz, and 19F-NMR 376 MHz). 1H-NMR spectra are reported as follows: chemical shift in ppm (δ) relative to the chemical shift of CHCl3 at 7.26 ppm or tetramethylsilane at 0 ppm, integration, multiplicities (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), and coupling constants (Hz). 13C-NMR spectra are reported in ppm (δ) relative to the central line of triplet for CDCl3 at 77 ppm. CF3CO2H was used as an external standard for 19F. ESI-MS spectra were obtained with Thermo Fisher, Exactive (Waltham, MA, USA). FT-IR spectra were recorded on a JASCO FT-IR system (FT/IR-4X). HPLC analyses were performed on a JASCO HPLC system (JASCO PU 980 pump and UV-975 UV/Vis detector, Halifax, NS, Canada). Mp was measured with AS ONE ATM-02. Column chromatography on SiO2 and neutral SiO2 was performed with Kanto Silica Gel 60 (40–50 μm). All reactions were carried out under Ar atmosphere unless otherwise noted. Commercially available organic and inorganic compounds were purchased from TCI (Tokyo, Japan), Kanto Chemical Co. Inc. (Tokyo, Japan), Wako Pure Chemical Industries, Ltd. (Osaka, Japan), or Nacalai Tesque, Inc. (Kyoto, Japan), which had >95% purities, and were used without further purification. All dehydrated solvents were purchased from Wako Pure Chemical Industries, Ltd. or Nacalai Tesque, Inc., and were used without further purification.

3.1. Synthesis of Substrates and a Catalyst

Imine substrates 1 and 1a′ were synthesized according to the reported procedures [41,42,45]. Azo compounds were purchased from a commercial source. Chiral catalyst 4 was synthesized according to the reported procedure [42].

3.2. Synthesis of 1,2,4-Triazolines

3.2.1. General Procedure for Table 1

A solution of 1a (1.0 equiv) in an appropriate solvent (0.05 M) was stirred for 10 min at the reaction temperature, and 2a (2.0 equiv) was added followed by DBU (appropriate amount). The reaction was stirred for an appropriate time at the same temperature before stopping the reaction. For the short-column procedure, the reaction mixture was directly passed through the short column (SiO2, ethyl acetate only) and evaporated to give the crude mixture. The NMR yield was determined by measuring its 1H-NMR after adding 1,3,5-trimethoxybenzene as an internal standard. For the extraction procedure, the reaction was quenched by the addition of excess amount of sat. NH4Cl aq. at the reaction temperature, which was extracted with CH2Cl2, dried over Na2SO4, and filtered. After the removal of solvent by evaporation, the crude product was obtained. The NMR yield was determined by measuring its 1H-NMR after adding 1,3,5-trimethoxybenzene as an internal standard. 3aa was isolated through the purification by column chromatography (neutral silica gel, hexane/dichloromethane/diethylether = 7/2/1).

3.2.2. General Procedure for Scheme 1, Scheme 2, Scheme 3 and Scheme 4 (Optimized Protocol)

A solution of 1 (1.0 equiv) in CH2Cl2 (0.05 M) was stirred for 10 min at 0 °C, to which 2 (2.0 equiv) was added, followed by DBU (50 mol%). The reaction was stirred for 1 h at 0 °C before quenching the reaction. The reaction was quenched by the addition of an excess amount of sat. NH4Cl aq. at the reaction temperature, which was extracted with CH2Cl2, dried over Na2SO4, and filtered. After the removal of solvent by evaporation, the crude product was obtained. The pure 3 was isolated through purification by column chromatography (neutral silica gel, hexane/dichloromethane/diethylether = 7/2/1).

  • 3-(tert-butyl) 1,2-diisopropyl 5-(4-nitrophenyl)-3-phenyl-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3aa), White solid, 19.4 mg, 0.036 mmol, 72% yield (0.050 mmol scale reaction). m.p. 68–70 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.00–8.04 (m, 2H), 7.68–7.72 (m, 2H), 7.34–7.43 (m, 3H), 5.10 (sep, J = 6.2 Hz, 1H), 4.81 (sep, J = 6.2 Hz, 1H), 1.40 (s, 9H), 1.39 (d, J = 6.2 Hz, 3H), 1.36 (d, J = 6.2 Hz, 3H), 1.12 (d, J = 6.2 Hz, 3H), 1.11 (d, J = 6.2 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.5, 156.5, 154.5, 152.2, 149.4, 137.0, 135.0, 130.8, 128.5, 127.8, 127.3, 122.9, 95.3, 83.7, 72.5, 71.4, 27.6, 22.2, 21.8, 21.53, 21.46; HRMS (ESI+ in MeCN) calcd. for C27H33O8N4+ (M + H) 541.2293 found 541.2297; IR (KBr) ν 2982, 1752, 1527, 1349, 1260, 1155, 1102, 849 cm−1.

  • tri-isopropyl 5-(4-nitrophenyl)-3-phenyl-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ba), White solid, 12.8 mg, 0.024 mmol, 44% yield (0.055 mmol scale reaction). m.p. 60–62 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.02–8.06 (m, 2H), 7.65–7.69 (m, 2H), 7.35–7.44 (m, 3H), 5.08 (sep, J = 6.2 Hz, 1H), 5.03 (sep, J = 6.2 Hz, 1H), 4.84 (sep, J = 6.2 Hz, 1H), 1.37 (d, J = 6.2 Hz, 3H), 1.33 (d, J = 6.2 Hz, 3H), 1.22 (d, J = 6.2 Hz, 3H), 1.18 (d, J = 6.2 Hz, 3H), 1.13 (d, J = 6.2 Hz, 3H), 1.12 (d, J = 6.2 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 166.4, 156.8, 154.2, 152.1, 149.5, 136.8, 134.7, 130.9, 128.7, 127.9, 127.2, 122.9, 94.6, 72.7, 71.4, 71.1, 22.1, 21.7, 21.52, 21.45; HRMS (ESI+ in MeCN) calcd. for C26H31O8N4+ (M + H) 527.2136 found 527.2241; IR (KBr) ν 2983, 1751, 1527, 1349, 1256, 1183, 1099, 849 cm−1.

  • 1,2-diisopropyl 3-methyl 5-(4-nitrophenyl)-3-phenyl-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ca), White solid, 7.6 mg, 0.016 mmol, 23% yield (0.069 mmol scale reaction). m.p. 60–62 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.31 (m, 2H), 8.04–8.08 (m, 2H), 7.66–7.70 (m, 2H), 7.37–7.46 (m, 3H), 5.11 (sep, J = 6.4 Hz, 1H), 4.83 (sep, J = 6.4 Hz, 1H), 3.76 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.32 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 167.5, 157.1, 154.2, 151.9, 149.5, 136.6, 134.4, 131.1, 128.9, 128.1, 127.1, 122.9, 94.3, 72.8, 71.6, 53.6, 22.0, 21.7, 21.54, 21.47; HRMS (ESI+ in MeCN) calcd. for C24H27O8N4+ (M + H) 499.1823 found 499.1828; IR (KBr) ν 2983, 1748, 1526, 1349, 1254, 1184, 1102, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 5-(4-nitrophenyl)-3-(o-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3da), White solid, 16.6 mg, 0.299 mmol, 60% yield (0.050 mmol scale reaction). m.p. 81–83 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.25–8.29 (m, 2H), 7.96–8.00 (m, 2H), 7.67 (d, J = 7.7 Hz, 1H), 7.25–7.30 (m, 2H), 7.17–7.22 (m, 1H), 5.09 (sep, J = 6.4 Hz, 1H), 4.86 (sep, J = 6.4 Hz, 1H), 2.62 (s, 3H), 1.42 (s, 9H), 1.38 (d, J = 6.4 Hz, 6H), 1.20 (d, J = 6.4 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.0, 155.9, 154.5, 152.2, 149.3, 137.5, 135.0, 134.7, 131.6, 130.9, 128.7, 126.7, 125.5, 122.9, 96.9, 83.6, 72.5, 71.4, 27.5, 22.1, 21.99, 21.85, 21.64, 21.58; HRMS (ESI+ in MeCN) calcd. for C28H35O8N4+ (M + H) 555.2449 found 555.2449; IR (KBr) ν 2982, 1744, 1527, 1349, 1257, 1157, 1103, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 5-(4-nitrophenyl)-3-(m-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ea), White solid, 14.8 mg, 0.027 mmol, 53% yield (0.050 mmol scale reaction). m.p. 96–98 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.04–8.00 (m, 2H), 7.50 (s, 1H), 7.48 (d, J = 6.8 Hz, 1H), 7.28–7.32 (m, 1H), 7.18 (d, J = 7.8 Hz, 1H), 5.11 (sep, J = 6.3 Hz, 1H), 4.81 (sep, J = 6.3 Hz, 1H), 2.40 (s, 3H), 1.40 (s, 9H), 1.39 (d, J = 6.3 Hz, 3H), 1.36 (d, J = 6.3 Hz, 3H), 1.14 (d, J = 6.3 Hz, 6H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.5, 156.3, 154.5, 152.2, 149.4, 137.4, 136.9, 135.0, 130.8, 129.3, 127.93, 127.81, 124.5, 122.9, 95.4, 83.6, 72.6, 71.3, 27.6, 22.2, 21.8, 21.59, 21.56, 21.48; HRMS (ESI+ in MeCN) calcd. for C28H35O8N4+ (M + H) 555.2449 found 555.2454; IR (KBr) ν 2981, 1747, 1526, 1348, 1253, 1155, 1103, 845 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 5-(4-nitrophenyl)-3-(p-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3fa), White solid, 16.8 mg, 0.030 mmol, 61% yield (0.050 mmol scale reaction). m.p. 76–78 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 7.99–8.03 (m, 2H), 7.55–7.59 (m, 2H), 7.21 (d, J = 8.0 Hz, 2H), 5.09 (sep, J = 6.3 Hz, 1H), 4.81 (sep, J = 6.3 Hz, 1H), 2.37 (s, 3H), 1.40 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H), 1.20 (d, J = 6.4 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.6, 156.3, 154.5, 152.2, 149.3, 138.4, 135.1, 134.0, 130.7, 128.6, 127.2, 122.9, 95.3, 83.6, 72.6, 71.3, 27.6, 22.2, 21.8, 21.56, 21.45, 21.1; HRMS (ESI+ in MeCN) calcd. for C28H35O8N4+ (M + H) 555.2449 found 555.2455; IR (KBr) ν 2982, 1747, 1526, 1348, 1258, 1155, 1102, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 3-(4-methoxyphenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ga), White solid, 18.6 mg, 0.033 mmol, 65% yield (0.050 mmol scale reaction). m.p. 98–100 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.00–8.04 (m, 2H), 7.59–7.63 (m, 2H), 6.91–6.95 (m, 2H), 5.09 (sep, J = 6.4 Hz, 1H), 4.81 (sep, J = 6.4 Hz, 1H), 3.83 (s, 3H), 1.40 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H), 1.10 (d, J = 6.4 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.7, 159.7, 156.3, 154.5, 152.2, 149.3, 135.1, 130.7, 129.1, 128.6, 122.9, 113.2, 95.0, 83.6, 72.6, 71.3, 55.2, 27.6, 22.2, 21.8, 21.56, 21.44; HRMS (ESI+ in MeCN) calcd. for C28H35O9N4+ (M + H) 571.2399 found 571.2404; IR (KBr) ν 2980, 1757, 1526, 1348, 1253, 1155, 1102, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 3-(4-bromophenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ha), White solid, 13.3 mg, 0.215 mmol, 43% yield (0.050 mmol scale reaction). m.p. 156–158 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.27–8.31 (m, 2H), 7.99–8.03 (m, 2H), 7.51–7.59 (m, 4H), 5.10 (sep, J = 6.3 Hz, 1H), 4.82 (sep, J = 6.3 Hz, 1H), 1.40 (s, 9H), 1.39 (d, J = 6.3 Hz, 3H), 1.36 (d, J = 6.3 Hz, 3H), 1.13 (d, J = 6.3 Hz, 3H), 1.11 (d, J = 6.3 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.0, 156.7, 154.5, 152.0, 149.5, 136.3, 134.8, 131.0, 130.8, 129.1, 122.99, 122.00, 94.8, 84.1, 72.8, 71.6, 27.6, 22.2, 21.8, 21.56, 21.42; HRMS (ESI+ in MeCN) calcd. for C27H32O8N4Br+ (M + H) 619.1398 found 619.1402; IR (KBr) ν 2981, 1751, 1526, 1348, 1257, 1155, 1102, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 3-(4-chlorophenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ia), White solid, 14.4 mg, 0.025 mmol, 50% yield (0.050 mmol scale reaction). m.p. 154–156 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.27–8.31 (m, 2H), 7.99–8.03 (m, 2H), 7.61–7.65 (m, 2H), 7.35–7.40 (m, 2H), 5.10 (sep, J = 6.4 Hz, 1H), 4.82 (sep, J = 6.4 Hz, 1H), 1.40 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 6.4 Hz, 3H), 1.11 (d, J = 6.4 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.2, 156.7, 154.5, 152.0, 149.4, 135.7, 134.8, 134.5, 130.8, 128.8, 128.0, 123.0, 94.8, 84.1, 72.8, 71.6, 27.6, 22.2, 21.8, 21.54, 21.42; HRMS (ESI+ in MeCN) calcd. for C27H32O8N4Cl+ (M + H) 575.1903 found 575.1910; IR (KBr) ν 2981, 1751, 1527, 1351, 1259, 1155, 1102, 849 cm−1.

  • 3-(tert-butyl) 1,2-diisopropyl 5-(4-nitrophenyl)-3-(4-(trifluoromethyl)phenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ja), White solid, 12.7 mg, 0.021mmol, 42% yield (0.050 mmol scale reaction). m.p. 77–79 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.27–8.32 (m, 2H), 8.00–8.04 (m, 2H), 7.83 (d, J = 8.0 Hz, 2H), 7.67 (d, J = 8.3 Hz, 2H), 5.12 (sep, J = 6.3 Hz, 1H), 4.82 (sep, J = 6.3 Hz, 1H), 1.40 (s, 9H), 1.39 (d, J = 6.3 Hz, 3H), 1.37 (d, J = 6.3 Hz, 3H), 1.13 (d, J = 6.3 Hz, 3H), 1.10 (d, J = 6.3 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.0, 157.0, 154.5, 151.9, 149.5, 141.1, 134.6, 130.86, 130.71 (q, J = 32.3 Hz), 127.8, 124.8 (q, J = 3.9 Hz), 123.9 (q, J = 272.8 Hz), 123.0, 94.8, 84.3, 72.9, 71.7, 27.6, 22.2, 21.8, 21.54, 21.40; 19F-NMR (376 MHz, CHLOROFORM-D) δ -62.5; HRMS (ESI+ in MeCN) calcd. for C28H32O8N4F3+ (M + H) 609.2167 found 609.2172; IR (KBr) ν 2983, 1752,1528,1326, 1257, 1165, 1102, 850 cm−1.

  • 3-(tert-butyl) 1,2-diethyl 5-(4-nitrophenyl)-3-phenyl-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3cb), White solid, 13.6 mg, 0.027 mmol, 53% yield (0.050 mmol scale reaction). m.p. 67–69 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.01–8.05 (m, 2H), 7.68–7.72 (m, 2H), 7.35–7.45 (m, 3H), 4.38–4.46 (m, 1H), 4.20–4.30 (m, 1H), 4.05–4.18 (m, 2H), 1.40 (s, 9H), 1.36 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 Hz, 3H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.4, 156.2, 154.9, 152.4, 149.4, 136.8, 134.8, 130.8, 128.6, 127.9, 127.3, 123.0, 95.5, 83.9, 64.1, 63.1, 27.6, 14.4, 13.8; HRMS (ESI+ in MeCN) calcd. for C25H29O8N4+ (M + H) 513.1980 found 513.1984; IR (KBr) ν 2980, 1752, 1526, 1351, 1258, 1153, 1022, 845 cm−1.

  • tri-tert-butyl 5-(4-nitrophenyl)-3-phenyl-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ac), White solid, 22.4 mg, 0.039 mmol, 78% yield (0.050 mmol scale reaction). Large-scale synthesis was conducted using 1.0 mmol (340.4 mg) of 1a, and 0.79 mmol (447.5 mg, 79% yield) of 3ac was isolated. m.p. 87–89 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 7.99–8.03 (m, 2H), 7.68–7.71 (m, 2H), 7.33–7.44 (m, 3H), 1.58 (s, 9H), 1.41 (s, 9H), 1.29 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.9, 156.6, 153.5, 151.0, 149.3, 137.3, 135.4, 130.7, 128.4, 127.8, 127.3, 122.9, 94.8, 84.8, 83.6, 83.0, 28.2, 27.6 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C29H37O8N4+ (M + H) 569.2606 found 569.2615; IR (KBr) ν 2979, 1744, 1527, 1369, 1349, 1253, 1149, 849 cm−1; HPLC (CHIRALPAK AD-H column, hexane/2-propanol = 95/5, flow rate 1.0 mL/min, 25 °C, 254 nm) first peak: tR = 5.8 min and second peak: tR = 6.7 min.

  • tri-tert-butyl 5-(4-nitrophenyl)-3-(o-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3dc), White solid, 19.0 mg, 0.033 mmol, 65% yield (0.050 mmol scale reaction). m.p. 99–101 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.25–8.29 (m, 2H), 7.94–7.98 (m, 2H), 7.70 (d, J = 7.5 Hz, 1H), 7.19–7.29 (m, 3H), 2.62 (s, 3H), 1.58 (s, 9H), 1.42 (s, 9H), 1.36 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.5, 156.0, 153.7, 151.0, 149.2, 137.5, 135.4, 135.0, 131.6, 130.8, 128.6, 126.6, 125.5, 122.9, 96.4, 84.8, 83.6, 83.0, 28.2, 27.7, 27.5, 22.0; HRMS (ESI+ in MeCN) calcd. for C30H39O8N4+ (M + H) 583.2762 found 583.2767; IR (KBr) ν 2979, 1742, 1527, 1369, 1348, 1254, 1150, 849 cm−1.

  • tri-tert-butyl 5-(4-nitrophenyl)-3-(m-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ec), White solid, 23.0 mg, 0.039 mmol, 79% yield (0.050 mmol scale reaction). m.p. 76–78 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 7.99–8.03 (m, 2H), 7.50 (s, 1H), 7.49 (d, J = 7.7 Hz, 1H), 7.28–7.33 (m, 1H), 7.17 (d, J = 7.8 Hz, 1H), 2.41 (s, 3H), 1.58 (s, 9H), 1.42 (s, 9H), 1.31 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.9, 156.5, 153.5, 151.0, 149.2, 137.3, 137.1, 135.4, 130.7, 129.2, 127.9, 127.7, 124.5, 122.9, 94.9, 84.7, 83.5, 82.9, 28.2, 27.6, 21.6 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C30H39O8N4+ (M + H) 583.2762 found 583.2770; IR (KBr) ν 2979, 1743, 1526, 1369, 1348, 1257, 1149, 851 cm−1.

  • tri-tert-butyl 5-(4-nitrophenyl)-3-(p-tolyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3fc), White solid, 21.4 mg, 0.0367 mmol, 73% yield (0.050 mmol scale reaction). m.p. 96–98 °C;1H-NMR (400 MHz, CHLOROFORM-D) δ 8.25–8.30 (m, 2H), 7.98–8.02 (m, 2H), 7.56–7.59 (m, 2H), 7.22 (d, J = 8.0 Hz, 2H), 2.38 (s, 3H), 1.57 (s, 9H), 1.41 (s, 9H), 1.29 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 166.0, 156.5, 153.4, 151.0, 149.2, 138.2, 135.5, 134.3, 130.7, 128.5, 127.2, 122.9, 94.8, 84.7, 83.5, 82.9, 28.2, 27.6, 21.1 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C30H39O8N4+ (M + H) 583.2762 found 583.2767; IR (KBr) ν 2979, 1744, 1527, 1369, 1348, 1254, 1150, 850 cm−1.

  • tri-tert-butyl 3-(4-methoxyphenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3gc), White solid, 24.4 mg, 0.041 mmol, 82% yield (0.050 mmol scale reaction). m.p. 87–89 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 7.98–8.02 (m, 2H), 7.59–7.64 (m, 2H), 6.91–6.96 (m, 2H), 3.83 (s, 3H), 1.58 (s, 9H), 1.41 (s, 9H), 1.29 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 166.1, 159.6, 156.5, 153.4, 151.0, 149.2, 135.5, 130.6, 129.4, 128.6, 122.9, 113.2, 94.5, 84.7, 83.5, 82.9, 55.2, 28.2, 27.6 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C30H39O9N4+ (M + H) 599.2712 found 599.2715; IR (KBr) ν 2979, 1744, 1527, 1369, 1348, 1253, 1150, 849 cm−1.

  • tri-tert-butyl 3-(4-bromophenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3hc), White solid, 27.0 mg, 0.042 mmol, 83% yield (0.050 mmol scale reaction). m.p. 94–96 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 7.97–8.00 (m, 2H), 7.52–7.60 (m, 4H), 1.58 (s, 9H), 1.41 (s, 9H), 1.29 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.6, 157.0, 153.4, 150.8, 149.3, 136.6, 135.2, 130.9, 130.7, 129.1, 123.0, 122.7, 94.2, 85.1, 84.2, 83.2, 28.2, 27.6 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C29H36O8N4Br+ (M + H) 647.1711 found 647.1721; IR (KBr) ν 2979, 1751, 1527, 1369, 1348, 1253, 1149, 849 cm−1.

  • tri-tert-butyl 3-(4-chlorophenyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3ic), White solid, 25.4 mg, 0.042 mmol, 84% yield (0.050 mmol scale reaction). m.p. 86–88 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.31 (m, 2H), 7.97–8.02 (m, 2H), 7.62–7.66 (m, 2H), 7.36–7.40 (m, 2H), 1.58 (s, 9H), 1.41 (s, 9H), 1.28 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.6, 156.9, 153.4, 150.8, 149.3, 136.0, 135.2, 134.4, 130.7, 128.8, 128.0, 123.0, 94.3, 85.0, 84.0, 83.2, 28.2, 27.6 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C29H36O8N4Cl+ (M + H) 603.2216 found 603.2227; IR (KBr) ν 2979, 1752, 1527,1369, 1348, 1255, 1149, 848 cm−1.

  • tri-tert-butyl 5-(4-nitrophenyl)-3-(4-(trifluoromethyl)phenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3jc), White solid, 27.7 mg, 0.044 mmol, 87% yield (0.050 mmol scale reaction). m.p. 106–108 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.27–8.31 (m, 2H), 7.98–8.02 (m, 2H), 7.84 (d, J = 8.2 Hz, 2H), 7.67 (d, J = 8.2 Hz, 2H), 1.59 (s, 9H), 1.41 (s, 9H), 1.28 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 165.5, 157.1, 153.5, 150.7, 149.4, 141.4, 135.1, 130.8, 130.5 (q, J = 33.1 Hz), 127.8, 124.8 (q, J = 3.7 Hz), 124.0 (q, J = 273.1 Hz), 123.0, 94.3, 85.1, 84.2, 83.4, 28.2, 27.6 (1 peak is overlapped with the other peak); 19F-NMR (376 MHz, CHLOROFORM-D) δ -62.5; HRMS (ESI+ in MeCN) calcd. for C30H36O8N4F3+ (M + H) 637.2480 found 637.2484; IR (KBr) ν 2980, 1751, 1528, 1370, 1326, 1253, 1149, 850 cm−1.

  • tri-tert-butyl 3-(naphthalen-2-yl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3kc), White solid, 23.6 mg, 0.038 mmol, 76% yield (0.050 mmol scale reaction). m.p. 108–110 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.26–8.30 (m, 2H), 8.13 (s, 1H), 8.00–8.04 (m, 2H), 7.83–7.91 (m, 4H), 7.46–7.53 (m, 2H), 1.61 (s, 9H), 1.43 (s, 9H), 1.31 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 166.0, 156.8, 153.6, 151.0, 149.3, 135.3, 134.83 133.3, 132.7, 130.8, 128.4, 127.6, 127.3, 126.4, 126.02, 125.96, 125.7, 123.0, 95.0, 84.8, 83.9, 83.1, 28.2, 27.7 (1 peak is overlapped with the other peak); HRMS (ESI+ in MeCN) calcd. for C33H39O8N4+ (M + H) 619.2762 found 619.2767; IR (KBr) ν 2979, 1746, 1526, 1369, 1348, 1252, 1149, 851 cm−1.

  • tri-tert-butyl 3-(tert-butyl)-5-(4-nitrophenyl)-1H-1,2,4-triazole-1,2,3(3H)-tricarboxylate (3lc), White solid, 7.92 mg, 0.014 mmol, 29% yield (0.050 mmol scale reaction). m.p. 68–70 °C; 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.27–8.31 (m, 2H), 7.91–7.95 (m, 2H), 1.56 (s, 9H), 1.40 (s, 9H), 1.30 (s, 9H), 1.19 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 164.8, 155.9, 154.6, 150.7, 149.0, 136.4, 130.0, 123.0, 98.7, 84.3, 82.8, 82.6, 39.1, 28.1, 27.76, 27.62, 25.2; HRMS (ESI+ in MeCN) calcd. For C27H41O8N4+ (M + H) 549.2919 found 549.2920; IR (KBr) ν 2979, 1758, 1528, 1370, 1348, 1255, 1149, 850 cm−1.

3.2.3. General Procedure for Scheme 5 (for the Synthesis of 5ac)

A solution of 1a (1.0 equiv) and 4 (2 mol%) in CH2Cl2 (0.05 M) was stirred for 10 min at 0 °C, to which 2c (2.0 equiv) was added, followed by potassium hydroxyde (50% aq., 150 mol%). The reaction was stirred for 48 h at 0 °C before quenching the reaction. The reaction was quenched by the addition of an excess amount of sat. NH4Cl aq. at the reaction temperature, which was extracted with CH2Cl2, dried over Na2SO4, and filtered. After the removal of solvent by evaporation, the crude product was obtained. The pure 5ac was isolated through purification by column chromatography (neutral silica gel, hexane/dichloromethane/diethylether = 7/2/1) in 53% yield.

  • di-tert-butyl (Z)-1-(((2-(tert-butoxy)-2-oxo-1-phenylethylidene)amino)(4-nitrophenyl)methyl)hydrazine-1,2-dicarboxylate (5ac), White solid, 30.3 mg, 0.053 mmol, 53% yield (0.10 mmol scale reaction). m.p. 85–87 °C: 1H-NMR (400 MHz, CHLOROFORM-D) δ 8.15 (d, J = 8.8 Hz, 2H), 7.84–7.86 (m, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.49–7.53 (m, 1H), 7.42–7.46 (m, 2H), 6.88 (br, 1H), 6.50 (br, 1H), 1.48 (s, 9H), 1.46 (s, 9H), 1.31 (s, 9H); 13C-NMR (101 MHz, CHLOROFORM-D) δ 163.4, 162.2, 154.4, 147.8, 145.4, 133.9, 131.8, 128.9, 128.6, 127.9, 123.0, 84.9, 82.4, 80.9, 28.2, 28.08, 28.01 (2 peaks are overlapped with the other peaks); HRMS (ESI+ in MeCN) calcd. for C29H39O8N4+ (M + H) 571.2762 found 571.2761; IR (KBr) ν 2979, 1727, 1525, 1368, 1346, 1259, 1153, 854 cm−1.

3.2.4. General Procedure for Scheme 5 (for the Synthesis of 3ac)

A solution of 5ac (1.0 equiv) in CH2Cl2 (0.05 M) was stirred for 10 min at 0 °C, which 2c (1.0 equiv) was added, followed by DBU (50 mol%). The reaction was stirred for 1 h at 0 °C before quenching the reaction. The reaction was quenched by the addition of an excess amount of sat. NH4Cl aq. at the reaction temperature, which was extracted with CH2Cl2, dried over Na2SO4, and filtered. After the removal of solvent by evaporation, the crude product was obtained. The pure 3ac was isolated through the purification by column chromatography (neutral silica gel, hexane/dichloromethane/diethylether = 7/2/1) in a 47% yield as a racemate.

Enantiomeric excess was determined by HPLC (CHIRALPAK AD-H, hexane/2-propanol = 95/5, flow rate 1.0 mL/min, 25 °C, 254 nm): first peak: tR = 5.8 min and second peak: tR = 6.8 min.

3.2.5. General Procedure for Scheme 6

A solution of 1a′ (1.0 equiv) and 4 (2 mol%) in CH2Cl2 (0.05 M) was stirred for 10 min at 0 °C, to which 2c (2.0 equiv) was added, followed by potassium hydroxyde (50% aq., 150 mol%). The reaction was stirred for 18 h at 0 °C before quenching the reaction. The reaction was quenched by the addition of an excess amount of sat. NH4Cl aq. at the reaction temperature, which was extracted with CH2Cl2, dried over Na2SO4, and filtered. After the removal of solvent by evaporation, the crude product was obtained. The pure 3ac was isolated through the purification by column chromatography (neutral silica gel, hexane/dichloromethane/diethylether = 7/2/1) in a 65% yield as a racemate.

Enantiomeric excess was determined by HPLC (CHIRALPAK AD-H, hexane/2-propanol = 95/5, flow rate 1.0 mL/min, 25 °C, 254 nm): first peak: tR = 5.8 min and second peak: tR = 6.8 min.

4. Conclusions

This study developed a direct synthesis method of 1,2,4-triazolines from easily accessible α-imino esters using commercial azo compounds under DBU catalysis, which provided excellent product yields. The study on the substrate scope revealed that the present reaction could be applied to a wide range of substrates and reactants, irrespective of their steric and electronic characteristics. The present reaction is the first general method for the metal-free preparation of 3-aryl pentasubstituted 1,2,4-triazolines under the mild condition. The reaction mechanism suggests that the α-imino ester reacts through the 2-aza allyl anion intermediate. However, its isomerized aldimine reacts with the enolate intermediate. We are further investigating the application of these products in the preparation of useful molecules.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28114339/s1, It contains 1H, 13C, and 19F NMR charts and HPLC spectra of the products and intermediates.

Click here for additional data file. (6.1MB, zip)

Author Contributions

Conceptualization, Y.Y.; Methodology, Y.Y., H.I., T.M. and M.S.; Investigation, H.I.; Data Curation, Y.Y. and H.I.; Writing—Original Draft Preparation, Y.Y.; Writing—Review and Editing, Y.Y. and H.I.; Visualization, Y.Y. and H.I.; Supervision, Y.Y.; Project Administration, Y.Y.; Funding Acquisition, Y.Y., T.M. and M.S. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are included in the manuscript or Supplementary Data File. All the known compounds were prepared according to previously reported procedures.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

Funding Statement

This research was funded by the IAAR Research Support Program, Chiba University, Japan, a Grant-in-Aid for Early Career Scientists (No. JP22K14674) from the JSPS, and the Leading Research Promotion Program “Soft Molecular Activation” of Chiba University, Japan.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Murphy M., Bernard E.M., Ishimaru T., Armstrong D. Activity of voriconazole (UK-109496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 1997;41:696–698. doi: 10.1128/AAC.41.3.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Moosa M.-Y.S., Sobel J.D., Elhalis H., Du W., Akins R.A. Fungicidal Activity of Fluconazole against Candida Albicans in a Synthetic Vagina-Simulative Medium. Antimicrob. Agents Chemother. 2004;48:161–167. doi: 10.1128/AAC.48.1.161-167.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Abdelli A., Azzouni S., Plais R., Gaucher A., Efrit M.L., Prim D. Recent advances in the chemistry of 1,2,4-triazoles: Synthesis, reactivity and biological activities. Tetrahedron Lett. 2021;86:153518. doi: 10.1016/j.tetlet.2021.153518. [DOI] [Google Scholar]
  • 4.Imberg L., Platte S., Erbacher C., Daniliuc C.G., Kalinina S.A., Dorner W., Poso A., Karst U., Kalinin D.V. Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin. ACS Pharmacol. Transl. Sci. 2022;5:1318–1347. doi: 10.1021/acsptsci.2c00204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Riederer S.K.U., Bechlars B., Herrmann W.A., Kühn F.E. Chiral N-heterocyclic biscarbenes based on 1,2,4-triazole as ligands for metal-catalyzed asymmetric synthesis. Dalton Trans. 2011;40:41–43. doi: 10.1039/C0DT00724B. [DOI] [PubMed] [Google Scholar]
  • 6.Yang X., Birman V.B. Acyl transfer catalysis with 1,2,4-triazole anion. Org. Lett. 2009;11:1499–1502. doi: 10.1021/ol900098q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kerr M.S., Rovis T. Enantioselective Synthesis of Quaternary Stereocenters via a Catalytic Asymmetric Stetter Reaction. J. Am. Chem. Soc. 2004;126:8876–8877. doi: 10.1021/ja047644h. [DOI] [PubMed] [Google Scholar]
  • 8.Huang H., Guo W., Wu W., Li C.-J., Jiang H. Copper-Catalyzed Oxidative C(sp3)-H Functionalization for Facile Synthesis of 1,2,4-Triazoles and 1,3,5-Triazines from Amidines. Org. Lett. 2015;17:2894–2897. doi: 10.1021/acs.orglett.5b00995. [DOI] [PubMed] [Google Scholar]
  • 9.Liu J., Jiang J., Zheng L., Liu Z.-Q. Recent Advances in the Synthesis of Nitrogen Heterocycles Using Arenediazonium Salts as Nitrogen Sources. Adv. Synth. Catal. 2020;362:4876–4895. doi: 10.1002/adsc.202000700. [DOI] [Google Scholar]
  • 10.Liu J.Q., Shen X.Y., Wang Y.H., Wang X.S., Bi X.H. [3 + 2] Cycloaddition of Isocyanides with Aryl Diazonium Salts: Catalyst-Dependent Regioselective Synthesis of 1,3- and 1,5-Disubstituted 1,2,4-Triazoles. Org. Lett. 2018;20:6930–6933. doi: 10.1021/acs.orglett.8b03069. [DOI] [PubMed] [Google Scholar]
  • 11.Li Y., Ye Z., Chen N., Chen Z., Zhang F. Intramolecular electrochemical dehydrogenative N–N bond formation for the synthesis of 1,2,4-triazolo [1,5-a]pyridines. Green Chem. 2019;21:4035–4039. doi: 10.1039/C9GC01895F. [DOI] [Google Scholar]
  • 12.Ueda S., Nagasawa H. Facile Synthesis of 1,2,4-Triazoles via a Copper-Catalyzed Tandem Addition–Oxidative Cyclization. J. Am. Chem. Soc. 2009;131:15080–15081. doi: 10.1021/ja905056z. [DOI] [PubMed] [Google Scholar]
  • 13.Shang E., Zhang J., Bai J., Wang Z., Li X., Zhu B., Lei X. Syntheses of [1,2,4]Triazolo [1,5-a]benzazoles Enabled by the Transition-Metal-Free Oxidative N–N Bond Formation. Chem. Commun. 2016;52:7028–7031. doi: 10.1039/C6CC01976E. [DOI] [PubMed] [Google Scholar]
  • 14.Eliseeva A.I., Nesterenko O.O., Slepukhin P.A., Benassi E., Belskaya N.P. Synthesis and Fluorescent Behaviour of 2-Aryl-4,5-dihydro-1H-1,2,4-triazoles. J. Org. Chem. 2017;82:86–100. doi: 10.1021/acs.joc.6b02144. [DOI] [PubMed] [Google Scholar]
  • 15.Peng X., Zhang F.-G., Ma J.-A. Cu-Catalysed three-component reaction of aryldiazonium salts with fluorinated diazo reagents and nitriles: Access to difluoro- and trifluoromethylated N1-aryl-1,2,4-triazoles. Adv. Synth. Catal. 2020;362:4432–4437. doi: 10.1002/adsc.202000776. [DOI] [Google Scholar]
  • 16.Matsuzaki H., Takeda N., Yasui M., Okazaki M., Suzuki S., Ueda M. Synthesis of multi-substituted 1,2,4-triazoles utilising the ambiphilic reactivity of hydrazones. Chem. Commun. 2021;57:12187–12190. doi: 10.1039/D1CC05326D. [DOI] [PubMed] [Google Scholar]
  • 17.Liu X., Li W., Jiang W., Lu H., Liu J., Lin Y., Cao H. Cu(II)-catalyzed C–H amidation/cyclization of azomethine imines with dioxazolones via acyl nitrenes: A direct access to diverse 1,2,4-triazole derivatives. Org. Lett. 2022;24:613–618. doi: 10.1021/acs.orglett.1c04044. [DOI] [PubMed] [Google Scholar]
  • 18.Hirayama T., Watanabe M., Akazawa C., Ishigami M., Fujikawa F., Kasahara T., Otsuka M., Nishida N., Mizuno D. Anti-tumor Activities of Some Heterocyclic and Nitrogen-containing Compounds. Yakugaku Zazzhi. 1980;100:1225–1234. doi: 10.1248/yakushi1947.100.12_1225. [DOI] [PubMed] [Google Scholar]
  • 19.Saleem R.S.Z., Tepe J.J. Synthesis of 1,2,4-Triazolines and Triazoles Utilizing Oxazolones. J. Org. Chem. 2010;75:4330–4332. doi: 10.1021/jo100716m. [DOI] [PubMed] [Google Scholar]
  • 20.Ibata T., Suga H., Isogami Y., Tamura H., Shi X. Abnormal Diels–Alder Reaction of Oxazoles with 4-Phenyl-3H-1,2,4-triazole-3,5(4H)-dione and Diethyl Azodicarboxylate, and X-Ray Crystal Structure of an Adduct. Bull. Chem. Soc. Jpn. 1992;65:2998–3007. doi: 10.1246/bcsj.65.2998. [DOI] [Google Scholar]
  • 21.Monge D., Jensen K.L., Marín I., Jørgensen K.A. Synthesis of 1,2,4-Triazolines: Base-Catalyzed Hydrazination/Cyclization Cascade of α-Isocyano Esters and Amides. Org. Lett. 2011;13:328–331. doi: 10.1021/ol102812c. [DOI] [PubMed] [Google Scholar]
  • 22.Wang M., Liu X.-H., He P., Lin L.-L., Feng X.-M. Enantioselective synthesis of 1,2,4-triazolines by chiral iron(ii)-complex catalyzed cyclization of α-isocyano esters and azodicarboxylates. Chem. Commun. 2013;49:2572–2574. doi: 10.1039/c3cc39088h. [DOI] [PubMed] [Google Scholar]
  • 23.Zhao M.-X., Bi H.-L., Zhou H., Yang H., Shi M. Cinchona Alkaloid Squaramide Catalyzed Enantioselective Hydrazination/Cyclization Cascade Reaction of α-Isocyanoacetates and Azodicarboxylates. J. Org. Chem. 2013;78:9377–9382. doi: 10.1021/jo401585v. [DOI] [PubMed] [Google Scholar]
  • 24.Shao Q., Chen J., Tu M., Piotrowski D.W., Huang Y. Enantioselective Synthesis of 1,2,4-Triazolines Catalyzed by a Cinchona Alkaloid-derived Organocatalyst. Chem. Commun. 2013;49:1098–11100. doi: 10.1039/c3cc46757k. [DOI] [PubMed] [Google Scholar]
  • 25.Ma B.-W., Luo W.-W., Lin L.-L., Liu X.-H., Feng X.-M. A chiral cobalt(ii) complex catalyzed asymmetric formal [3 + 2] cycloaddition for the synthesis of 1,2,4-triazoline. Chem. Commun. 2017;53:4077–4079. doi: 10.1039/C7CC01278K. [DOI] [PubMed] [Google Scholar]
  • 26.Wang H., Ren Y., Wang K., Man Y., Xiang Y., Li N., Tang B. Visible light-induced cyclization reactions for the synthesis of 1,2,4-triazolines and 1,2,4-triazoles. Chem. Commun. 2017;53:9644–9647. doi: 10.1039/C7CC04911K. [DOI] [PubMed] [Google Scholar]
  • 27.Hashimoto T., Maruoka K. Recent Development and Application of Chiral Phase-Transfer Catalysts. Chem. Rev. 2007;107:5656–5682. doi: 10.1021/cr068368n. [DOI] [PubMed] [Google Scholar]
  • 28.Lasch R., Heinrich M.R. Cycloaddition reactions of glycine imine anions to phenylazocarboxylic esters—A new access to 1,3,5-trisubstituted 1,2,4-triazoles. Tetrahedron. 2015;71:4282–4295. doi: 10.1016/j.tet.2015.04.078. [DOI] [Google Scholar]
  • 29.Eftekhari-Sis B., Zirak M. α-Imino Esters in Organic Synthesis: Recent Advances. Chem. Rev. 2017;117:8326–8419. doi: 10.1021/acs.chemrev.7b00064. [DOI] [PubMed] [Google Scholar]
  • 30.Mazuela J., Antonsson T., Johansson M.J., Knerr L., Marsden S.P. Direct Synthesis of N-Alkyl Arylglycines by Organocatalytic Asymmetric Transfer Hydrogenation of N-Alkyl Aryl Imino Esters. Org. Lett. 2017;19:5541–5544. doi: 10.1021/acs.orglett.7b02627. [DOI] [PubMed] [Google Scholar]
  • 31.Chen J., Li F., Wang F., Hu Y., Zhang Z., Zhao M., Zhang W. Pd(OAc)2-Catalyzed Asymmetric Hydrogenation of α-Iminoesters. Org. Lett. 2019;21:9060–9065. doi: 10.1021/acs.orglett.9b03452. [DOI] [PubMed] [Google Scholar]
  • 32.Hu X.H., Hu X.P. Ir-Catalyzed Asymmetric Hydrogenation of α-Imino Esters with Chiral Ferrocenylphosphine-Phosphoramidite Ligands. Adv. Synth. Catal. 2019;361:5063–5068. doi: 10.1002/adsc.201900888. [DOI] [Google Scholar]
  • 33.Kim J., Shin M., Cho S.H. Copper-catalyzed diastereoselective and enantioselective addition of 1, 1-diborylalkanes to cyclic ketimines and α-imino esters. ACS Catal. 2019;9:8503–8508. doi: 10.1021/acscatal.9b02931. [DOI] [Google Scholar]
  • 34.Liu D., Li B., Chen J., Gridnev I.D., Yan D., Zhang W. Ni-catalyzed asymmetric hydrogenation of N-aryl imino esters for the efficient synthesis of chiral α-aryl glycines. Nat. Commun. 2020;11:5935. doi: 10.1038/s41467-020-19807-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cabré A., Verdaguer X., Riera A. Recent Advances in the Enantioselective Synthesis of Chiral Amines via Transition Metal-Catalyzed Asymmetric Hydrogenation. Chem. Rev. 2022;122:269–339. doi: 10.1021/acs.chemrev.1c00496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wu Y., Hu L., Li Z., Deng L. Catalytic asymmetric umpolung reactions of imines. Nature. 2015;523:445–450. doi: 10.1038/nature14617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mizota I., Shimizu M. Umpolung Reactions of α-Imino Esters: Useful Methods for the Preparation of α-Amino Acid Frameworks. Chem. Rec. 2016;16:688–702. doi: 10.1002/tcr.201500267. [DOI] [PubMed] [Google Scholar]
  • 38.Chen P., Yue Z., Zhang J., Lv X., Wang L., Zhang J. Phosphine-Catalyzed Asymmetric Umpolung Addition of Trifluoromethyl Ketimines to Morita–Baylis–Hillman Carbonates. Angew. Chem. Int. Ed. 2016;55:13316–13320. doi: 10.1002/anie.201607918. [DOI] [PubMed] [Google Scholar]
  • 39.Su Y.-L., Li Y.-H., Chen Y.-G., Han Z.-Y. Ir/PTC Cooperatively Catalyzed Asymmetric Umpolung Allylation of α-Imino Ester Enabled Synthesis of α-Quaternary Amino Acid Derivatives Bearing Two Vicinal Stereocenters. Chem. Commun. 2017;53:1985–1988. doi: 10.1039/C6CC09654A. [DOI] [PubMed] [Google Scholar]
  • 40.Feng B., Lu L.-Q., Chen J.-R., Feng G., He B.-Q., Lu B., Xiao W.-J. Umpolung of Imines Enables Catalytic Asymmetric Regio-reversed [3 + 2] Cycloadditions of Iminoesters with Nitroolefins. Angew. Chem. Int. Ed. 2018;57:5888–5892. doi: 10.1002/anie.201802492. [DOI] [PubMed] [Google Scholar]
  • 41.Yoshida Y., Mino T., Sakamoto M. Organocatalytic Highly Regio- and Enantioselective Umpolung Michael Addition Reaction of α-Imino Esters. Chem. Eur. J. 2017;23:12749–12753. doi: 10.1002/chem.201703479. [DOI] [PubMed] [Google Scholar]
  • 42.Yoshida Y., Moriya Y., Mino T., Sakamoto M. Regio- and Enantioselective Synthesis of α-Amino-δ-Ketoesters Through Catalytic Umpolung Reaction of α-Iminoesters with Enones. Adv. Synth. Catal. 2018;360:4142–4146. doi: 10.1002/adsc.201800791. [DOI] [Google Scholar]
  • 43.Yoshida Y., Hiroshige T., Omori K., Mino T., Sakamoto M. Chemo- and Regioselective Asymmetric Synthesis of Cyclic Enamides through the Catalytic Umpolung Organocascade Reaction of α-Imino Amides. J. Org. Chem. 2019;84:7362–7371. doi: 10.1021/acs.joc.9b01036. [DOI] [PubMed] [Google Scholar]
  • 44.Yoshida Y., Omori K., Hiroshige T., Mino T., Sakamoto M. Chemoselective Catalytic Asymmetric Synthesis of Functionalized Aminals Through the Umpolung Organocascade Reaction of α-Imino Amides. Chem.-Asian J. 2019;14:2737–2743. doi: 10.1002/asia.201900764. [DOI] [PubMed] [Google Scholar]
  • 45.Yoshida Y., Kukita M., Omori K., Mino T., Sakamoto M. Iminophosphorane-mediated regioselective umpolung alkylation reaction of α-iminoesters, Org. Biomol. Chem. 2021;19:4551–4564. doi: 10.1039/D1OB00596K. [DOI] [PubMed] [Google Scholar]
  • 46.Zhou X., Wu Y., Deng L. Cinchonium Betaines as Efficient Catalysts for Asymmetric Proton Transfer Catalysis: The Development of a Practical Enantioselective Isomerization of Trifluoromethyl Imines. J. Am. Chem. Soc. 2016;138:12297–12302. doi: 10.1021/jacs.6b08727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wang G., Piva de Silva G., Wiebe N.E., Fehr G.M., Davis R.L. Development of a Metal–Free Amine Oxidation Method Utilizing DEAD Chemistry. RSC Adv. 2017;7:48848–48852. doi: 10.1039/C7RA09165F. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (6.1MB, zip)

Data Availability Statement

Data are included in the manuscript or Supplementary Data File. All the known compounds were prepared according to previously reported procedures.

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES